GLOBAL DRUG DISCOVERY MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

GLOBAL DRUG DISCOVERY MARKET 2019-2028

Market by Drug Type, Technology, Service, End-user, and Region | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The global drug discovery market was projected to grow at a CAGR of 6.50% during the forecasting years 2019-2028. It was valued at $43.073 billion in 2019, is expected to reach $75.893 billion by 2028. Drug discovery is the process of identification, synthesis, classification, screening, and assaying of novel chemical candidates that could be developed into latent drugs.


Report scope can be customized per your requirements. Request For Customization

Along with the drug discovery services providers, the market for drug discovery devices and technologies is also witnessing a rise. Drug discovery technologies are used for the synthesis and extraction of the target compounds. Some of these technologies include qPCR, microarrays, high throughput screening, and others. Furthermore, the preference for small molecules, along with the growing technological advancements and the disease complications, lead the key players to surge their R&D expenditure, which is a key driver for the drug discovery market.


The study aims to get an overview of the drug discovery market in terms of various factors. The market definition and the key insights regarding the drug discovery industry have been discussed within the report. Also, Porter's five forces model, COVID-19 and its impact on the drug discovery market, regulatory outlook, market attractiveness index, and PESTLE outlook have been studied in detail.

Market drivers like the growing old age population, technological advancements, rise in healthcare expenditure, and rise in lifestyle-oriented diseases are driving the drug discovery market growth. However, the industry is facing restraints like the delay in the launch of the products and the restricted development rate due to generic drugs that are obstructing the industry growth.

Key opportunities like substantial investment by healthcare organizations in improving big data analytical abilities and the growing demand for specialty medications can be leveraged by the industry to reach the projected growth. However, challenges such as poor reimbursements procedures in developing nations and strict government guidelines are being faced by this market.

Geographies covered in the drug discovery market by region are:

•           North America: Canada and United States

•           Europe: United Kingdom, Germany, Italy, Spain, France, Russia, and Rest of Europe

•        Asia-Pacific: India, China, South Korea, ASEAN countries, Japan, Australia & New Zealand, and Rest of Asia-Pacific

•           Latin America: Brazil, Mexico, and Rest of Latin America

•           Middle East and Africa: Turkey, South Africa, United Arab Emirates, Saudi Arabia, and Rest of Middle East & Africa

The drug discovery market has been segmented as follows:

•           By Technology

O         Nanotechnology

O         Combinatorial chemistry

O         Pharmacogenetics and pharmacogenomics

O         High throughput screening

O         Metabolomics

O         Bioinformatics

O         Spectroscopy

O         Biochips

O         Other technologies

•           By Drug Type

O         Biologic drug

O         Small molecule drug

•           By Service

O         Drug metabolism and pharmacokinetics (DMPK) services

O         Chemical services

O         Biological services

O         Other pharmaceutical services

•           By End-user

O         Contract research organizations (CROS)

O         Research institutes

O         Pharmaceutical companies

O         Other end-users

The key players engaged in the drug discovery market are Sanofi, Novartis, GlaxoSmithKline LLC, Bayer AG, Pfizer Inc, Johnson & Johnson, Eli Lily and anofi, Novartis, GlaxoSmithKline LLC, Bayer AG, Pfizer Inc, Johnson & Johnson, Eli Lily and Company, Abbott Laboratories Inc, AstraZeneca Plc, Antares Pharma Inc, Merck & Co Inc, 3M Company, F Hoffmann-La Roche Ltd, Agilent Technologies Inc, Boehringer Ingelheim, and Becton Dickinson & Company (BD).

The strategic analysis for each of these companies has been covered in detail. The drug discovery market by company profiles that helps to dive into the info about the key players in this industry and the hold they have on the market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL DRUG DISCOVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER'S FIVE FORCES MODEL

2.2.1.   THREATS OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. COVID-19 AND ITS IMPACT ON DRUG DISCOVERY MARKET

2.4. PESTLE OUTLOOK

2.5. REGULATORY FRAMEWORK

2.6. VALUE CHAIN OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   GROWING AGED POPULATION

2.9.2.   TECHNOLOGICAL ADVANCEMENTS

2.9.3.   RISE IN HEALTHCARE EXPENDITURE

2.9.4.   SURGE IN LIFESTYLE-ORIENTED DISEASES

2.10.  MARKET RESTRAINTS

2.10.1.   DELAY IN PRODUCT LAUNCHES

2.10.2.     RESTRICTED GROWTH RATE DUE TO GENERIC DRUGS

2.11.     MARKET OPPORTUNITIES

2.11.1.    SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG DATA ANALYTICAL CAPABILITIES

2.11.2.  RISING DEMAND FOR SPECIALTY MEDICINES

2.12.   MARKET CHALLENGES

2.12.1.   POOR REIMBURSEMENTS POLICIES IN EMERGING NATIONS

2.12.2.     STRINGENT GOVERNMENT REGULATIONS

3.    DRUG DISCOVERY MARKET OUTLOOK - BY DRUG TYPE

3.1. SMALL MOLECULE DRUG

3.2. BIOLOGIC DRUG

4.    DRUG DISCOVERY MARKET OUTLOOK - BY TECHNOLOGY

4.1. HIGH THROUGHPUT SCREENING

4.2. BIOCHIPS

4.3. BIOINFORMATICS

4.4. PHARMACOGENOMICS AND PHARMACOGENETICS

4.5. COMBINATORIAL CHEMISTRY

4.6. NANOTECHNOLOGY

4.7. SPECTROSCOPY

4.8. METABOLOMICS

4.9. OTHER TECHNOLOGIES

5.    DRUG DISCOVERY MARKET OUTLOOK - BY SERVICE

5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES

5.2. CHEMICAL SERVICES

5.3. BIOLOGICAL SERVICES

5.4. OTHER PHARMACEUTICAL SERVICES

6.    DRUG DISCOVERY MARKET OUTLOOK - BY END-USER

6.1. RESEARCH INSTITUTES

6.2. PHARMACEUTICAL COMPANIES

6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.4. OTHER END-USERS

7.    DRUG DISCOVERY MARKET – REGIONAL OUTLOOK

7.1. NORTH AMERICA

7.1.1.   MARKET BY TECHNOLOGY

7.1.2.   MARKET BY DRUG TYPE

7.1.3.   MARKET BY SERVICE

7.1.4.   MARKET BY END-USER

7.1.5.   COUNTRY ANALYSIS

7.1.5.1.      UNITED STATES

7.1.5.2.      CANADA

7.2. EUROPE

7.2.1.   MARKET BY TECHNOLOGY

7.2.2.   MARKET BY DRUG TYPE

7.2.3.   MARKET BY SERVICE

7.2.4.   MARKET BY END-USER

7.2.5.   COUNTRY ANALYSIS

7.2.5.1.      THE UNITED KINGDOM

7.2.5.2.      FRANCE

7.2.5.3.      GERMANY

7.2.5.4.      SPAIN

7.2.5.5.      ITALY

7.2.5.6.      RUSSIA

7.2.5.7.      REST OF EUROPE

7.3. ASIA-PACIFIC

7.3.1.   MARKET BY TECHNOLOGY

7.3.2.   MARKET BY DRUG TYPE

7.3.3.   MARKET BY SERVICE

7.3.4.   MARKET BY END-USER

7.3.5.   COUNTRY ANALYSIS

7.3.5.1.      CHINA

7.3.5.2.      INDIA

7.3.5.3.      JAPAN

7.3.5.4.      SOUTH KOREA

7.3.5.5.      AUSTRALIA & NEW ZEALAND

7.3.5.6.      ASEAN COUNTRIES

7.3.5.7.      REST OF ASIA-PACIFIC

7.4. LATIN AMERICA

7.4.1.   MARKET BY TECHNOLOGY

7.4.2.   MARKET BY DRUG TYPE

7.4.3.   MARKET BY SERVICE

7.4.4.   MARKET BY END-USER

7.4.5.   COUNTRY ANALYSIS

7.4.5.1.      BRAZIL

7.4.5.2.      MEXICO

7.4.5.3.      REST OF LATIN AMERICA

7.5. MIDDLE EAST AND AFRICA

7.5.1.   MARKET BY TECHNOLOGY

7.5.2.   MARKET BY DRUG TYPE

7.5.3.   MARKET BY SERVICE

7.5.4.   MARKET BY END-USER

7.5.5.   COUNTRY ANALYSIS

7.5.5.1.      SAUDI ARABIA

7.5.5.2.      TURKEY

7.5.5.3.      UNITED ARAB EMIRATES

7.5.5.4.      SOUTH AFRICA

7.5.5.5.      REST OF MIDDLE EAST & AFRICA

8.    COMPANY PROFILES

8.1. 3M COMPANY

8.2. ABBOTT LABORATORIES INC

8.3. AGILENT TECHNOLOGIES INC

8.4. ANTARES PHARMA INC

8.5. ASTRAZENECA PLC

8.6. BAYER AG

8.7. BECTON DICKINSON & COMPANY (BD)

8.8. BOEHRINGER INGELHEIM

8.9. ELI LILY AND COMPANY

8.10. F HOFFMANN-LA ROCHE LTD

8.11.  GLAXOSMITHKLINE LLC

8.12.    JOHNSON & JOHNSON

8.13.    MERCK & CO INC

8.14.     NOVARTIS

8.15.     PFIZER INC

8.16.       SANOFI

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE 2        GLOBAL DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 3        GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 4        GLOBAL DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 5        GLOBAL DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 6        GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE 7        NORTH AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 8        NORTH AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 9        NORTH AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 10      NORTH AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 11      NORTH AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 12      EUROPE DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 13      EUROPE DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 14      EUROPE DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 15      EUROPE DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 16      EUROPE DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 17      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 18      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 19      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 20      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 21      ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 22      LATIN AMERICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 23      LATIN AMERICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 24      LATIN AMERICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 25      LATIN AMERICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 26      LATIN AMERICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 27      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2028 ($ MILLION)

TABLE 28      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2028 ($ MILLION)

TABLE 29      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY SERVICE, 2019-2028 ($ MILLION)

TABLE 30      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 31      MIDDLE EAST AND AFRICA DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      GLOBAL DRUG DISCOVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

FIGURE 2      GLOBAL DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2028 ($ MILLION)

FIGURE 3      GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2028 ($ MILLION)

FIGURE 4      GLOBAL DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 ($ MILLION)

FIGURE 5      GLOBAL DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2028 ($ MILLION)

FIGURE 6      GLOBAL DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2028 ($ MILLION)

FIGURE 7      GLOBAL DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2028 ($ MILLION)

FIGURE 8      GLOBAL DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2028 ($ MILLION)

FIGURE 9      GLOBAL DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2028 ($ MILLION)

FIGURE 10   GLOBAL DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2028 ($ MILLION)

FIGURE 11   GLOBAL DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2028 ($ MILLION)

FIGURE 12   GLOBAL DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2028 ($ MILLION)

FIGURE 13   GLOBAL DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2028 ($ MILLION)

FIGURE 14   GLOBAL DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 15   GLOBAL DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 16   GLOBAL DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2028 ($ MILLION)

FIGURE 17   GLOBAL DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2028 ($ MILLION)

FIGURE 18   GLOBAL DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2028 ($ MILLION)

FIGURE 19   GLOBAL DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2028 ($ MILLION)

FIGURE 20   GLOBAL DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2028 ($ MILLION)

FIGURE 21   UNITED STATES DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 22   CANADA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 23   THE UNITED KINGDOM DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 24   FRANCE DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 25   GERMANY DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 26   SPAIN DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 27   ITALY DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 28   RUSSIA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 29   REST OF EUROPE DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 30   CHINA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 31   INDIA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 32   JAPAN DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 33   SOUTH KOREA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 34   AUSTRALIA & NEW ZEALAND DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 35   ASEAN COUNTRIES DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 36   REST OF ASIA-PACIFIC DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 37   BRAZIL DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 38   MEXICO DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 39   REST OF LATIN AMERICA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 40   SAUDI ARABIA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 41   TURKEY DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 42   UNITED ARAB EMIRATES DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 43   SOUTH AFRICA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

FIGURE 44   REST OF MIDDLE EAST & AFRICA DRUG DISCOVERY MARKET 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;